Results 71 to 80 of about 4,045,135 (314)

Advances in Molecular Serotyping and Subtyping of Escherichia coli† [PDF]

open access: yesFrontiers in Microbiology, 2016
Escherichia coli plays an important role as a member of the gut microbiota; however, pathogenic strains also exist, including various diarrheagenic E. coli pathotypes and extraintestinal pathogenic E. coli that cause illness outside of the GI-tract. E. coli have traditionally been serotyped using antisera against the ca.
Fratamico, Pina M.   +5 more
openaire   +3 more sources

Multi-Omics Analysis Detects Novel Prognostic Subgroups of Breast Cancer

open access: yesFrontiers in Genetics, 2020
The unprecedented proliferation of recent large-scale and multi-omics databases of cancers has given us many new insights into genomic and epigenomic deregulation in cancer discovery in general. However, we wonder whether or not there exists a systematic
Quang-Huy Nguyen   +5 more
doaj   +1 more source

What is a Bladder Cancer Molecular Subtype? – Counterpoint

open access: yesBladder Cancer, 2023
In an accompanying paper, Mattias Höglund discusses on what is a bladder cancer molecular subtype. He emphasizes the need to consider the aim of tumor classification, which is obviously critical to the approach. He also focuses on considering primarily the identity features of the neoplastic cells. Here, we provide a counterpoint.
Radvanyi, François   +2 more
openaire   +2 more sources

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

open access: yesMolecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur   +11 more
wiley   +1 more source

Association between polymorphism Cdx2 and Molecular subtypes.

open access: yes, 2015
P-value (Chi-Square test) = 0.05.Association between polymorphism Cdx2 and Molecular subtypes.
Etleva Korita (717922)   +11 more
core   +1 more source

Prognostic Importance of PTEN and P53 in Aggressive Luminal A Subtype Breast Cancers

open access: yesEuropean Journal of Breast Health
Objective: While prognostic and predictive factors in breast cancer are well established, data on aggressive behavior in luminal A subtype breast cancers are limited.
Öykü Dila Gemci   +5 more
doaj   +1 more source

Melanoma Molecular Subtypes: Unifying and Paradoxical Results [PDF]

open access: yesJournal of Investigative Dermatology, 2010
In this issue, Hacker and colleagues provide further evidence that molecular subtypes of malignant melanoma may develop along divergent pathways. The authors did not find an association between somatic BRAF-mutant melanoma and germline melanocortin-1 receptor (MC1R) gene status. We discuss this seeming paradox in light of previous studies demonstrating
Thomas, Nancy E.   +4 more
openaire   +2 more sources

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

The Role of Immunohistochemistry as a Surrogate Marker in Molecular Subtyping and Classification of Bladder Cancer

open access: yesDiagnostics
Background/Objectives: Bladder cancer (BC) is a highly heterogeneous disease, presenting clinical challenges, particularly in predicting patient outcomes and selecting effective treatments.
Tatiana Cano Barbadilla   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy